GEIST:UPC Searchengine

ORD_3985/2025

Newyu,Inc., Abbott Laboratories, Abbott Laboratories A/S, Abbott Scandinavia Aktiebolag, Abbott Diabetes Care Inc., Abbott GmbH, Abbott Logistics B.V., Abbott S.r.l., Abbott Gesellschaft m.b.H., Abbott Oy, Abbott Diagnostics GmbH, Abbott, Abbott B.V.

Date
2025-01-24
Division
Luxembourg (LU)
Type of action
Application Rop 265
Language
EN

Metadata

Case IDORD_3985-2025-0d775c636b93
Case number
Registry numberORD_3985/2025
Order referenceORD_3985/2025
Keywords
Headnotes

Documents and full text

Extractor: pypdf | Pages: 4

1 ORDER of the Court of Appeal of the Unified Patent Court issued on 24 January 2025 Withdrawal pursuant to R. 265 RoP and Application for reimbursement of Court fees (R. 370.9 RoP) HEADNOTES: - An application to withdraw an action pursuant to R.265 RoP can also be filed in appeal proceedings. It is only after the final decision has become legally binding that a filing of a withdrawal application is inadmissible. - With the closure of the proceedings, the impugned decision will become ineffective. KEYWORDS: Application to withdraw an action (R.265.1 RoP) APPELLANT (CLAIMANT AND COUNTERDEFENDANT BEFORE THE COURT OF FIRST INSTANCE) DexCom, Inc., San Diego, CA, USA (hereinafter ‘Dexcom‘) represented by: Anne-Charlotte Le Bihan, Attorney-at-law, and Laurent Labatte, European Patent Attorney (B ...